Neurodegenerative Science
Overview
Worldwide, between 7 million to 10 million people have Parkinson’s disease and more than 30 million have dementia. Currently, there is no cure and no effective way to slow or stop disease progression.
VAI scientists aim to change that by investigating the complex factors that give rise to neurodegenerative and psychiatric disorders, from genetics and epigenetics to aging, inflammation and the structure of the brain itself — even the role of the gut and the immune system. By leveraging discoveries made in VAI’s labs and collaborating with researchers around the world, our scientists are working to translate breakthroughs into life-changing new treatments for Parkinson’s, dementias and depression.
West Michigan Neurodegenerative Diseases (MiND) Program
Van Andel Institute’s West Michigan Neurodegenerative Diseases (MiND) Program is a collaborative effort to identify genetic and epigenetic changes that may play roles in neurodegenerative diseases, such as Parkinson’s and dementias. Our goal? To move the needle in our understanding of these diseases, power new discoveries and leverage our findings to inform groundbreaking treatment strategies.
Learn More
Our Faculty
Darren Moore, Ph.D.
Chair and Professor, Department of Neurodegenerative Science; Director, MiND Program
Molecular Neurodegeneration
Lena Brundin, M.D., Ph.D.
Professor, Department of Neurodegenerative Science
Behavioral Medicine
Hong-yuan Chu, Ph.D.
Assistant Professor, Department of Neurodegenerative Science
Neural Circuits and Neurodegeneration
Gerhard (Gerry) Coetzee, Ph.D.
Professor, Department of Neurodegenerative Science; Interim Dean, Van Andel Institute Graduate School
Post-GWAS Functionality
Michael Henderson, Ph.D.
Assistant Professor, Department of Neurodegenerative Science
Protein Pathologies and Genetic Risk in Neurodegeneration
Laurent Roybon, Ph.D.
Associate Professor, Department of Neurodegenerative Science; Director, MiND iPSC Program
Qiang Zhu, Ph.D.
Assistant Professor, Department of Neurodegenerative Science
Genetics, Epigenetics and Therapeutic Innovation in Neurodegenerative Diseases
